[Therapy of inflammatory diseases of the nervous system].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D008581:Meningitis / Q000188:drug therapy* / Q000382:microbiology; D008584:Meningitis, Listeria / Q000188:drug therapy; D008586:Meningitis, Pneumococcal / Q000188:drug therapy; D008590:Meningoencephalitis / Q000188:drug therapy*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy; D011115:Polyneuropathies / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy; D013449:Sulfonamides / Q000627:therapeutic use; D014390:Tuberculosis, Meningeal / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D013449:Sulfonamides
Therapie der entzündlichen Erkrankungen des Nervensystems.